FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136993148> ?p ?o ?g. }

• W3136993148 abstract "Abstract Background Stroke produces multiple symptoms, including sensory, motor, cognitive and psychological dysfunctions, among which motor deficit is the most common and is widely recognized as a major contributor to long-term functional disability. Robot-assisted training is effective in promoting upper extremity muscle strength and motor impairment recovery after stroke. Additionally, action observation treatment can enhance the effects of physical and occupational therapy by increasing neural activation. The AOT-EXO trial aims to investigate whether action observation treatment coupled with robot-assisted training could enhance motor circuit activation and improve upper extremity motor outcomes. Methods The AOT-EXO trial is a multicentre, prospective, three-group randomized controlled trial (RCT). We will screen and enrol 132 eligible patients in the trial implemented in the Department of Rehabilitation Medicine of Tongji Hospital, Optical Valley Branch of Tongji Hospital and Hubei Province Hospital of Integrated Chinese & Western Medicine in Wuhan, China. Prior to study participation, written informed consent will be obtained from eligible patients in accordance with the Declaration of Helsinki. The enrolled stroke patients will be randomized to three groups: the CT group (conventional therapy); EXO group (exoskeleton therapy) and AOT-EXO group (action observation treatment-based exoskeleton therapy). The patients will undergo blinded assessments at baseline, post-intervention (after 4 weeks) and follow-up (after 12 weeks). The primary outcome will be the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). Secondary outcomes will include the Action Research Arm Test (ARAT), modified Barthel Index (MBI), kinematic metrics assessed by inertial measurement unit (IMU), resting motor threshold (rMT), motor evoked potentials (MEP), functional magnetic resonance imaging (fMRI) and safety outcomes. Discussion This trial will provide evidence regarding the feasibility and efficacy of the action observation treatment-based exoskeleton (AOT-EXO) for post-stroke upper extremity rehabilitation and elucidate the potential underlying kinematic and neurological mechanisms. Trial registration Chinese Clinical Trial Registry ChiCTR1900026656 . Registered on 17 October 2019." @default.
• W3136993148 created "2021-03-29" @default.
• W3136993148 creator A5000063462 @default.
• W3136993148 creator A5018585853 @default.
• W3136993148 creator A5035301178 @default.
• W3136993148 creator A5045150883 @default.
• W3136993148 creator A5054193501 @default.
• W3136993148 creator A5064553173 @default.
• W3136993148 creator A5067409742 @default.
• W3136993148 date "2021-03-20" @default.
• W3136993148 modified "2023-10-02" @default.
• W3136993148 title "Action observation treatment-based exoskeleton (AOT-EXO) for upper extremity after stroke: study protocol for a randomized controlled trial" @default.
• W3136993148 cites W1484449035 @default.
• W3136993148 cites W1796989181 @default.
• W3136993148 cites W1874163255 @default.
• W3136993148 cites W1978666538 @default.
• W3136993148 cites W1985957289 @default.
• W3136993148 cites W2072805425 @default.
• W3136993148 cites W2079124738 @default.
• W3136993148 cites W2095244112 @default.
• W3136993148 cites W2098957888 @default.
• W3136993148 cites W2099864518 @default.
• W3136993148 cites W2115138492 @default.
• W3136993148 cites W2115362480 @default.
• W3136993148 cites W2119985669 @default.
• W3136993148 cites W2129416217 @default.
• W3136993148 cites W2139049236 @default.
• W3136993148 cites W2140123501 @default.
• W3136993148 cites W2162185620 @default.
• W3136993148 cites W2169876532 @default.
• W3136993148 cites W2212556151 @default.
• W3136993148 cites W2216043568 @default.
• W3136993148 cites W2240827217 @default.
• W3136993148 cites W2346795597 @default.
• W3136993148 cites W2511163921 @default.
• W3136993148 cites W2582144131 @default.
• W3136993148 cites W2742914643 @default.
• W3136993148 cites W2755624618 @default.
• W3136993148 cites W2755708327 @default.
• W3136993148 cites W2903428621 @default.
• W3136993148 cites W2921112006 @default.
• W3136993148 cites W2940528205 @default.
• W3136993148 cites W2946772588 @default.
• W3136993148 cites W2957884775 @default.
• W3136993148 cites W2971197848 @default.
• W3136993148 doi "https://doi.org/10.1186/s13063-021-05176-x" @default.
• W3136993148 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7981809" @default.
• W3136993148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33743788" @default.
• W3136993148 hasPublicationYear "2021" @default.
• W3136993148 type Work @default.
• W3136993148 sameAs 3136993148 @default.
• W3136993148 citedByCount "1" @default.
• W3136993148 countsByYear W31369931482022 @default.
• W3136993148 crossrefType "journal-article" @default.
• W3136993148 hasAuthorship W3136993148A5000063462 @default.
• W3136993148 hasAuthorship W3136993148A5018585853 @default.
• W3136993148 hasAuthorship W3136993148A5035301178 @default.
• W3136993148 hasAuthorship W3136993148A5045150883 @default.
• W3136993148 hasAuthorship W3136993148A5054193501 @default.
• W3136993148 hasAuthorship W3136993148A5064553173 @default.
• W3136993148 hasAuthorship W3136993148A5067409742 @default.
• W3136993148 hasBestOaLocation W31369931481 @default.
• W3136993148 hasConcept C127413603 @default.
• W3136993148 hasConcept C141071460 @default.
• W3136993148 hasConcept C146549078 @default.
• W3136993148 hasConcept C168563851 @default.
• W3136993148 hasConcept C1862650 @default.
• W3136993148 hasConcept C2778818304 @default.
• W3136993148 hasConcept C2780566999 @default.
• W3136993148 hasConcept C2780645631 @default.
• W3136993148 hasConcept C45391945 @default.
• W3136993148 hasConcept C71924100 @default.
• W3136993148 hasConcept C78519656 @default.
• W3136993148 hasConcept C99508421 @default.
• W3136993148 hasConceptScore W3136993148C127413603 @default.
• W3136993148 hasConceptScore W3136993148C141071460 @default.
• W3136993148 hasConceptScore W3136993148C146549078 @default.
• W3136993148 hasConceptScore W3136993148C168563851 @default.
• W3136993148 hasConceptScore W3136993148C1862650 @default.
• W3136993148 hasConceptScore W3136993148C2778818304 @default.
• W3136993148 hasConceptScore W3136993148C2780566999 @default.
• W3136993148 hasConceptScore W3136993148C2780645631 @default.
• W3136993148 hasConceptScore W3136993148C45391945 @default.
• W3136993148 hasConceptScore W3136993148C71924100 @default.
• W3136993148 hasConceptScore W3136993148C78519656 @default.
• W3136993148 hasConceptScore W3136993148C99508421 @default.
• W3136993148 hasFunder F4320321001 @default.
• W3136993148 hasIssue "1" @default.
• W3136993148 hasLocation W31369931481 @default.
• W3136993148 hasLocation W31369931482 @default.
• W3136993148 hasLocation W31369931483 @default.
• W3136993148 hasLocation W31369931484 @default.
• W3136993148 hasOpenAccess W3136993148 @default.
• W3136993148 hasPrimaryLocation W31369931481 @default.
• W3136993148 hasRelatedWork W1981454560 @default.
• W3136993148 hasRelatedWork W2028914704 @default.
• W3136993148 hasRelatedWork W2392087460 @default.
• W3136993148 hasRelatedWork W2743515813 @default.
• W3136993148 hasRelatedWork W2811043050 @default.
• W3136993148 hasRelatedWork W2898722424 @default.

• next